AnalystsInsight

Mark Fitzgibbon (Piper Sandler): Analyst Track Record and Price‑Target Accuracy

How often Mark Fitzgibbon’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 550 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Mark Fitzgibbon ranks #696 of 1,000 analysts in Exent’s scoring (4.7★).
  • 67.6% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 127 days; 70.9% of calls were up 12 months later.
  • Most‑covered stocks: NBBK, OBT, CBNA, EBC.
  • Free on Exent: Mark Fitzgibbon’s full record, with ratings 3 days after publication.

Mark Fitzgibbon’s track record at a glance

Mark Fitzgibbon of Piper Sandler ranks #696 of the 1,000 analysts Exent scores, with a 4.7★ rating and a focus on financials. Over a 7‑year lookback, 67.6% of Mark’s price targets were reached, 15.2 points above the 52.4% average across all analysts.

MetricMark FitzgibbonAll analysts
Price‑target hit rate67.6%52.4%
Median days to hit target127 days91 days
Calls up after 12 months70.9%64.0%
Median 12‑month return of calls+15.8%+13.4%
Hit rate, last 2 years77.9%—
Average worst drop after a call−15.4%—
Ratings in the sample550—
Stocks covered23—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetMark Fitzgibbon
Under 30 days12.9%
30–90 days28.7%
90–180 days21.6%
Over 180 days36.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Mark Fitzgibbon covers most

StockRatings in the sample
NBBK29
OBT28
CBNA28
EBC28
INDB27
NBN26
BHB23
MCB23

In the past year Mark’s ratings were 74% Buy, 22% Hold and 3% Sell.

Mark Fitzgibbon’s latest ratings

DateStockActionRatingPrice target
Feb 27, 2026PGCReiterated: BuyBuy$39.00
Feb 27, 2026PGCReiteratedBuy$39.00
Feb 18, 2026BBTMaintainedBuy$33.00
Feb 18, 2026BBTMaintained: BuyBuy$33.00
Feb 18, 2026BBTReiterated: BuyBuy$33.00
Feb 5, 2026OBTReiterated: BuyBuy$36.00
Feb 5, 2026OBTMaintained: BuyBuy$36.00
Feb 5, 2026OBTMaintainedBuy$36.00
Jan 30, 2026HNVRMaintained: BuyBuy$26.50
Jan 30, 2026HNVRMaintainedBuy$26.50
Jan 30, 2026HNVRReiterated: BuyBuy$26.50
Jan 29, 2026BBTMaintainedBuy$33.00
  • Feb 27, 2026
    Stock
    PGC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $39.00
  • Feb 27, 2026
    Stock
    PGC
    Action
    Reiterated
    Rating
    Buy
    Price target
    $39.00
  • Feb 18, 2026
    Stock
    BBT
    Action
    Maintained
    Rating
    Buy
    Price target
    $33.00
  • Feb 18, 2026
    Stock
    BBT
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $33.00
  • Feb 18, 2026
    Stock
    BBT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $33.00
  • Feb 5, 2026
    Stock
    OBT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $36.00
  • Feb 5, 2026
    Stock
    OBT
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $36.00
  • Feb 5, 2026
    Stock
    OBT
    Action
    Maintained
    Rating
    Buy
    Price target
    $36.00
  • Jan 30, 2026
    Stock
    HNVR
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $26.50
  • Jan 30, 2026
    Stock
    HNVR
    Action
    Maintained
    Rating
    Buy
    Price target
    $26.50
  • Jan 30, 2026
    Stock
    HNVR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $26.50
  • Jan 29, 2026
    Stock
    BBT
    Action
    Maintained
    Rating
    Buy
    Price target
    $33.00

Mark’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Mark Fitzgibbon’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Mark Fitzgibbon ranks #696 of 1,000 with a 4.7★ rating. 67.6% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 70.9% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Mark Fitzgibbon’s success rate is 65.1% by the ranking source and 67.6% by Exent’s price-target hit-rate backtest, with a median of 127 days to reach a target.

Mark Fitzgibbon (Piper Sandler) covers 23 stocks, mostly in financials. The most frequently rated are NBBK, OBT, CBNA, EBC, INDB.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.